Market News

US News

20 stories
zacks

PENG's CXL Bet Expands: Can It Become a Future Revenue Catalyst?

Penguin Solutions, Inc. PENG is expanding its CXL-powered AI memory portfolio, positioning the technology as a potential long-term revenue driver as enterprise AI shifts from model training to inference workloads. As AI inference becomes increasingly memory-intensive, management believes scalable m…

Zacks en
StocksUS
gurufocus

Starwood Raises $10.2 Billion as AI Reshapes Real Estate

Starwood Capital Group has raised $10.2 billion for its largest fund, as the firm positions itself around data centers, rental housing and other commercial real estate assets at a time when artificial intelligence is reshaping demand across property markets. Chairman Barry Sternlicht said Starwood…

GuruFocus en
StocksUS
acceswire

ELEKTROS Announces Smart Grid Intelligence Initiative Utilizing Agentic AI to Mitigate Extreme Heatwave Energy Demands

WEST PALM BEACH, FL / ACCESS Newswire / July 2, 2026 / ELEKTROS Inc. (OTC PINK:ELEK), an emerging company focused on energy solutions, announced that, following correspondence regarding U.S. Patent No. 12,522,100 B1, the Company has reviewed Jaguar Land Rover's response and has elected not to pursu…

ACCESS Newswire en
EconomyStocksUS

Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $386 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Over 283 Million WLD Tokens

Eightco treasury composition as of July 1, 2026: $90M OpenAI equity (indirect), $18M Beast Industries equity, 16,278 ETH, 283 million WLD holdings, and $149M cash and equivalents, totaling approximately $386 millionWorldcoin token (WLD) now listed on Robinhood NASDAQ:HOOD, expanding access to milli…

Chainwire en
CryptoStocksUS
zacks

Lilly Up Around 7% in a Week: Should You Buy, Sell or Hold the Stock?

Eli Lilly and Company’s LLY stock has risen around 6.7% in a week, backed by strong company-specific news and the overall recent rally in the U.S. drug and biotech sector. Eli Lilly stock hit a new 52-week high on June 26. Last week, the European Medicines Agency's Committee for Medicinal Products…

Zacks en
StocksUS

Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)

WSW, NY, July 2nd, 2026, FinanceWireThree years of war in Ukraine and the Middle East taught governments exactly what to stockpile. The first lesson was kinetic - and drone, missile, and surveillance stocks ripped. The second lesson may now be landing, and it appears to draw attention to a small bi…

FinanceWire en
StocksUS
stocktwits

PLTR Stock Rises Premarket – This Analyst Called Palantir A ‘Gift’ For Investors Ahead of Independence Day

Shares of Palantir (PLTR) drew investor attention premarket on Thursday after DA Davidson called the stock a ‘gift’ for investors ahead of the United States’ 250th independence day.DA Davidson upgraded Palantir’s rating to ‘Buy’ from ‘Neutral’ and hiked the stock’s price target to $175 from $165, a…

Stocktwits en
StocksUS
NEWS zacks

How Ouster's REV8 BABA Compliance Boosts Its Long-Term Outlook

Ouster's OUST Rev8 digital lidar sensors have achieved Build America, Buy America (“BABA”) Act compliance, making them eligible for deployment in federally funded U.S. infrastructure projects. The milestone opens the door to opportunities across intelligent transportation systems, smart cities, tra…

Zacks en
StocksUS
tradingview

Matthew N. Brams' trial period at Cingulate extended to Sep 30, 2026

Cingulate extended Matthew N. Brams' Trial Period as Executive Vice President and Chief Medical Officer to September 30, 2026.Original SEC Filing: Cingulate Inc. [ CING ] - 8-K - Jul. 02, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with t…

TradingView en
StocksUS